Pharmaceutical Formulation for topical Application of a nonsteroidal anti-inflammatory Drug (NSAID) spheroidal

摘要

1. The composition of special application of the national space research and development agency, which is characterized by that the composition includes the solution or suspension of the active components of the national space research and development agency as a carrier system, which is composed of a polyhydrate alcohol, a glycerin and a high fatty acid ester, and the carrier system exists as a simple stage a. Ambient temperature. 2. Composition according to the first requirement, as NSAU is an active ingredient, dichlorophenol. 3. Composition in accordance with Item 2,It is characterized by the presence of Dichlorophenol as a dichlorophenol acid. 4. The ingredient meeting any of the above requirements, which is characterized by that the polyhydrate alcohol contains a glycerin, preferably isopropylene glycol. 5. The composition meeting any of the above requirements is characterized by a bipolar problem. 6. The composition in accordance with claim 5, which is characterized in that polar fat comprises a chain asphalt ester made of saturated C12 to c20.7 carbolic acid derivatives.It is characterized by that the kale ether includes diethanol ether, preferably diethanol monoether. 8. Components meeting any of the above requirements, which are characterized by the following carrier components, with the proportion of 5-70% polyol, 20-60% glycerin and 2-70% ether by weight.